Advanced Science (Mar 2024)

X‐Ray Visible Protein Scaffolds by Bulk Iodination

  • Carlos Flechas Becerra,
  • Lady V. Barrios Silva,
  • Ebtehal Ahmed,
  • Joseph C. Bear,
  • Zhiping Feng,
  • David Y.S. Chau,
  • Samuel G. Parker,
  • Steve Halligan,
  • Mark F. Lythgoe,
  • Daniel J. Stuckey,
  • P. Stephen Patrick

DOI
https://doi.org/10.1002/advs.202306246
Journal volume & issue
Vol. 11, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Protein‐based biomaterial use is expanding within medicine, together with the demand to visualize their placement and behavior in vivo. However, current medical imaging techniques struggle to differentiate between protein‐based implants and surrounding tissue. Here a fast, simple, and translational solution for tracking transplanted protein‐based scaffolds is presented using X‐ray CT–facilitating long‐term, non‐invasive, and high‐resolution imaging. X‐ray visible scaffolds are engineered by selectively iodinating tyrosine residues under mild conditions using readily available reagents. To illustrate translatability, a clinically approved hernia repair mesh (based on decellularized porcine dermis) is labeled, preserving morphological and mechanical properties. In a mouse model of mesh implantation, implants retain marked X‐ray contrast up to 3 months, together with an unchanged degradation rate and inflammatory response. The technique's compatibility is demonstrated with a range of therapeutically relevant protein formats including bovine, porcine, and jellyfish collagen, as well as silk sutures, enabling a wide range of surgical and regenerative medicine uses. This solution tackles the challenge of visualizing implanted protein‐based biomaterials, which conventional imaging methods fail to differentiate from endogenous tissue. This will address previously unanswered questions regarding the accuracy of implantation, degradation rate, migration, and structural integrity, thereby accelerating optimization and safe translation of therapeutic biomaterials.

Keywords